{"id":"https://openalex.org/W4382344171","doi":"https://doi.org/10.1158/1078-0432.ccr-23-1194","title":"PD-1 Monotherapy Reigns Supreme in Adjuvant Melanoma\u2026But for How Long?","display_name":"PD-1 Monotherapy Reigns Supreme in Adjuvant Melanoma\u2026But for How Long?","publication_year":2023,"publication_date":"2023-06-28","ids":{"openalex":"https://openalex.org/W4382344171","doi":"https://doi.org/10.1158/1078-0432.ccr-23-1194","pmid":"https://pubmed.ncbi.nlm.nih.gov/37378689","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10527539"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-23-1194","doi":"https://doi.org/10.1158/1078-0432.ccr-23-1194","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-23-1194","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10527539/pdf/nihms-1909879.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048748333","display_name":"Ryan C. Augustin","orcid":"https://orcid.org/0000-0003-1296-4969","observed_orcids":["https://orcid.org/0000-0003-1296-4969"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan C. Augustin","raw_affiliation_strings":["1UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania","2University of Pittsburgh, Department of Medicine, Pittsburgh, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0003-1296-4969","affiliations":[{"raw_affiliation_string":"1UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]},{"raw_affiliation_string":"2University of Pittsburgh, Department of Medicine, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jason J. Luke","raw_affiliation_strings":["1UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania","2University of Pittsburgh, Department of Medicine, Pittsburgh, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0002-1182-4908","affiliations":[{"raw_affiliation_string":"1UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]},{"raw_affiliation_string":"2University of Pittsburgh, Department of Medicine, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5063337705"],"corresponding_institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210128526","https://openalex.org/I4210134769"],"apc_list":null,"apc_paid":null,"fwci":0.5203,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.62792496,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":95},"biblio":{"volume":"29","issue":"17","first_page":"3253","last_page":"3255"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7773000001907349,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7773000001907349,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.2206999957561493,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.7950000166893005},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/resectable-melanoma","display_name":"resectable melanoma","score":0.9340000152587891},{"id":"https://openalex.org/keywords/high-risk-melanoma","display_name":"high-risk melanoma","score":0.8830000162124634},{"id":"https://openalex.org/keywords/long-term-survival","display_name":"long-term survival","score":0.6349999904632568},{"id":"https://openalex.org/keywords/neoadjuvant-immunotherapy","display_name":"neoadjuvant immunotherapy","score":0.9070000052452087},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7480000257492065},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7577618360519409},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6714128851890564},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6087689399719238},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5914499759674072},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5758726596832275},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5064035654067993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4973771870136261},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.48372557759284973},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3729301989078522},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.13976863026618958}],"mesh":[{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000096142","descriptor_name":"Cutaneous Malignant Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-23-1194","doi":"https://doi.org/10.1158/1078-0432.ccr-23-1194","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-23-1194","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:37378689","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37378689","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10527539","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10527539","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10527539/pdf/nihms-1909879.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:10527539","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10527539","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10527539/pdf/nihms-1909879.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000856355","display_name":"NCI ETCTN Pittsburgh Cancer Consortium (PCC)","funder_award_id":"UM1CA186690","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000896014","display_name":"Melanoma and Skin Cancer Program SPORE","funder_award_id":"P50CA254865","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000897317","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA047904","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382344171.pdf","grobid_xml":"https://content.openalex.org/works/W4382344171.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W2070825440","https://openalex.org/W2529373149","https://openalex.org/W2752210999","https://openalex.org/W2752227448","https://openalex.org/W2762347490","https://openalex.org/W2797309423","https://openalex.org/W2891505315","https://openalex.org/W2900674262","https://openalex.org/W2949315168","https://openalex.org/W3017049470","https://openalex.org/W3126577181","https://openalex.org/W3164024551","https://openalex.org/W4206524087","https://openalex.org/W4220789323","https://openalex.org/W4229079437","https://openalex.org/W4295128346","https://openalex.org/W4297094017","https://openalex.org/W4307385288","https://openalex.org/W4322718735","https://openalex.org/W4324307212","https://openalex.org/W4365504267"],"related_works":["https://openalex.org/W3022782413","https://openalex.org/W7162568750","https://openalex.org/W3095465973","https://openalex.org/W2952517086","https://openalex.org/W4367173137","https://openalex.org/W4399264667","https://openalex.org/W2887734242","https://openalex.org/W7212116102","https://openalex.org/W2969691241","https://openalex.org/W2149715074"],"abstract_inverted_index":{"The":[0],"results":[1,33],"of":[2,10,26,37],"CheckMate-238":[3],"led":[4],"to":[5],"the":[6,23,35],"original":[7],"FDA":[8],"approval":[9],"anti-PD-1":[11],"therapy":[12],"in":[13,34],"high-risk,":[14],"resectable":[15],"melanoma.":[16],"In":[17],"this":[18,27],"CCR":[19],"Translations,":[20],"we":[21],"discuss":[22],"5-year":[24],"update":[25],"pivotal":[28],"trial":[29],"and":[30,45],"contextualize":[31],"its":[32],"face":[36],"limited":[38],"survival":[39],"data,":[40],"neoadjuvant":[41],"therapy,":[42],"next-generation":[43],"biomarkers,":[44],"novel":[46],"immunotherapy":[47],"combinations.":[48],"See":[49],"related":[50],"article":[51],"by":[52],"Larkin":[53],"et":[54],"al.,":[55],"p.":[56],"3352.":[57]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-06-29T00:00:00"}